Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Firebrick Pharma Limited ( (AU:FRE) ) just unveiled an update.
Firebrick Pharma Limited reported a significant increase in revenues from ordinary activities, rising by 1,853.33% to $293,000 for the year ended June 30, 2025, compared to the previous year. Despite this revenue growth, the company experienced a substantial net loss of $2.634 million, an increase of 124% from the prior year, highlighting ongoing financial challenges.
More about Firebrick Pharma Limited
Firebrick Pharma Limited operates in the pharmaceutical industry, focusing on the development and commercialization of innovative healthcare products.
Average Trading Volume: 94,704
Technical Sentiment Signal: Buy
For a thorough assessment of FRE stock, go to TipRanks’ Stock Analysis page.